Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trial Watch: Toll-like receptor agonists in cancer immunotherapy
Melody Smith, Elena García-Martínez, Michael Pitter, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1526250-e1526250
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1085
Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro, Pablo Sarobe, Sandra Hervás‐Stubbs, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 525-543
Open Access | Times Cited: 926
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 729
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Katie L. Owen, Natasha K. Brockwell, Belinda S. Parker
Cancers (2019) Vol. 11, Iss. 12, pp. 2002-2002
Open Access | Times Cited: 527
Trial watch: TLR3 agonists in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 224
Trial watch: STING agonists in cancer therapy
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 222
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 188
Macrophage targeting in cancer
Martha Lopez‐Yrigoyen, Luca Cassetta, Jeffrey W. Pollard
Annals of the New York Academy of Sciences (2020) Vol. 1499, Iss. 1, pp. 18-41
Open Access | Times Cited: 181
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 153
Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
Claire Vanpouille‐Box, Jules A. Hoffmann, Lorenzo Galluzzi
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 11, pp. 845-867
Closed Access | Times Cited: 147
Trial watch: IDO inhibitors in cancer therapy
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice
Julia Wagner, Dorothée Gößl, Natasha Ustyanovska Avtenyuk, et al.
ACS Nano (2021) Vol. 15, Iss. 3, pp. 4450-4466
Open Access | Times Cited: 132
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 124
Innate Immunity and Cancer Pathophysiology
Laura Maiorino, Juliane Daßler‐Plenker, Lijuan Sun, et al.
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 425-457
Open Access | Times Cited: 106
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 85
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
Christian Rolfo, Elisa Giovannetti, Pablo Martínez, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 83
The role of dendritic cells in cancer
Yoke Seng Lee, Kristen J. Radford
International review of cell and molecular biology (2019), pp. 123-178
Closed Access | Times Cited: 133
Type I interferons and dendritic cells in cancer immunotherapy
Jenny Sprooten, Patrizia Agostinis, Abhishek D. Garg
International review of cell and molecular biology (2019), pp. 217-262
Open Access | Times Cited: 116
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
Marco Tucci, Anna Passarelli, Francesco Mannavola, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 115
Immunotherapy in sepsis - brake or accelerate?
Folkert Steinhagen, Susanne V. Schmidt, Jens‐Christian Schewe, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107476-107476
Open Access | Times Cited: 108
Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
Jin Li, Diane J. Burgess
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2110-2124
Open Access | Times Cited: 97
Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance
Linlin Shi, Jianyong Sheng, Guozhong Chen, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000973-e000973
Open Access | Times Cited: 96
Opportunities for Small Molecules in Cancer Immunotherapy
Sabina Y. van der Zanden, Jolien J. Luimstra, Jacques Neefjes, et al.
Trends in Immunology (2020) Vol. 41, Iss. 6, pp. 493-511
Closed Access | Times Cited: 95
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
Rossella Sartorius, Maria Trovato, Roberta Manco, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 94
Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis
Jiang Yu, Qiuju Han, Huajun Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top